Abstract
The number of sound-induced flash illusions (SIFI) perceived are related with the level of visual cortex (V1) excitability. In episodic migraineurs, in response to visual-acoustic illusions, V1 is hyperexcitable. The injection of botulinum toxin type A was approved as a therapy for chronic migraine (CM). Recent studies have correlated the action of botulinum toxin with the release of CGRP and cortical excitability. We used SIFI to evaluate the V1 excitability in CM at baseline and 3 months after treatment with botulinum toxin.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
